Myeloid leukemia therapeutics market research report evaluates the therapeutics market of acute myeloid leukemia in G8 countries with respect to the current and pipeline drugs and regimens.
Since program implementation, the rates of ventilator-associated pneumonia, central line infections and pressure ulcers have decreased, intensive care unit (ICU) readmissions have declined, ICU length of stay remains low, and testing and pain management education have increased.